Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 December 2021 | Story Dr Nitha Ramnath

The University of the Free State will present the December 2021 graduation ceremonies virtually from 8 to 13 December 2021. The recent changes in our environment due to the discovery of the Omicron variant, and the increase in COVID-19 infection rates in South Africa, have required us to re-assess our plans.  This was also addressed as a matter of concern by President Cyril Ramaphosa during the family meeting on 28 November 2021. 

After careful consideration of the risks of presenting face-to-face graduation ceremonies, the executive management of the University of the Free State (UFS) has decided to adjust all the ceremonies to virtual broadcasts. 

The university community acknowledges your hard work and achievements in the midst of the many challenges you have faced. Despite not being able to meet in person, we are grateful that technology makes it possible to proceed with this significant event. 

The graduation ceremonies will be broadcast as follows:

Faculty of Education, South Campus: Wednesday, 8 December 2021 at 09:00

Faculty of Education, South Campus graduands: Wednesday, 8 December 2021 at 11:00

Faculty of Education, Bloemfontein Campus and Qwaqwa Campus graduands: Thursday, 9 December 2021 at 09:00

Faculty of Economic and Management Sciences: Thursday, 9 December at 11:00

Faculty of Natural and Agricultural Sciences: Friday, 10 December at 09:00

Faculty of the Humanities: Friday, 10 December 2021 at 11:00

Faculties of Health Sciences, Law, and Theology and Religion: Monday, 13 December 2021 at 09:00

Congratulations to all our graduates; may you have continued success in all your endeavours! 

 


News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept